Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
about
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastasesRadiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.Reassessing target antigens for adoptive T-cell therapy.Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.Checkpoint blockade in cancer immunotherapySignaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.Melanocyte receptors: clinical implications and therapeutic relevance.Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.Ipilimumab-induced toxicities and the gastroenterologist.Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathiesRadiation therapy and immunotherapy: what is the optimal timing or sequencing?Optimizing Radiotherapy with Immunotherapeutic Approaches.Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.
P2860
Q33620317-7A5530EE-5ED3-4FC7-AFDF-DF85AEDBF7BCQ34278609-2A0D512F-B193-4544-B635-4EE80E077BE1Q34789569-E787BE1C-3818-4331-8901-BBCEA43AA75AQ35534956-4667C89E-25D8-4761-B9F8-1218B44133D6Q36260666-3C0736D0-BAE7-4523-B04B-A2F337C845FFQ36490768-A18C6F20-F1CC-496C-8A66-E3C768E6F4FEQ36522770-0647789C-EAF5-4443-85AE-A88941CAAC9EQ36569004-06790E0C-5BE2-4D27-9AB3-66AAA15B89CCQ36954814-D59D5DDB-9686-4B5F-8FDC-852FC562A5BEQ37002020-5E99F18F-C71D-40B2-9A8A-1F6692B8174BQ38340321-B503C21B-756E-4B85-B16F-46129CAC5765Q39009781-84DE95F6-043A-4F4D-88BF-6534C6477449Q39010566-AD7B06C9-633E-40FD-AB48-B4C55C61CA56Q50109474-2515EE8D-9F73-4119-B8A9-9435655583D1Q52888621-3203E86C-9301-449B-93CE-4EA93F9D73B4Q55283310-FB836C19-7EB0-4271-96C3-B86B71B45CC6
P2860
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@ast
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@en
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@nl
type
label
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@ast
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@en
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@nl
prefLabel
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@ast
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@en
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@nl
P2093
P2860
P1476
Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
@en
P2093
Christian S Hinrichs
Douglas C Palmer
Nicholas P Restifo
Steven A Rosenberg
P2860
P304
P356
10.1097/01.CJI.0000177999.95831.7B
P577
2005-11-01T00:00:00Z